{
    "code": "52026627",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026627",
    "time": "2020-12-18 03:16:05",
    "許可證字號": "衛部藥輸字第026627號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/11\/30",
    "發證日期": "104\/11\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202662707",
    "中文品名": "健達必注射劑",
    "英文品名": "DBL Gemcitabine for Injection",
    "適應症": "非小細胞肺癌，胰臟癌，膀胱癌。Gemcitabine與paclitaxel併用，可使用於曾經使用過anthracycline之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(Platinum-Based)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。膽道癌。",
    "劑型": "270注射劑",
    "包裝": "5.3毫升玻璃小瓶裝 26.3毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GEMCITABINE HYDROCHLORIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0567000  ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED",
            "製造廠廠址": "PHARMEZ SPECIAL ECONOMIC ZONE, PLOT NO.3, SARKHEJ-BAVLA ROAD, N.H. NO. 8A, VILLAGE: MATODA, TALUKA: SANAND, DISTRICT-AHMEDABAD-382 213 (GUJARAT), INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "equiv. to 1.00g gemcitabine base",
            "含量": "1.1390000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "equiv. to 200mg gemcitabine base",
            "含量": "227.7000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Gemcitabine 1g26.3ml小瓶-106-09-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=002&Type=10"
        },
        {
            "title": "Gemcitabine 200mg5.3ml小瓶-106-09-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "申復擬稿. DBL Gemcitabine Solution for Injection LLD MOH 20190415-2-109-11-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=004&Type=9"
        },
        {
            "title": "Gemcitabine 1g26.3ml外盒中文標籤-106-09-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=003&Type=8"
        },
        {
            "title": "Gemcitabine 200mg5.3ml外盒中文標籤-106-09-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=002&Type=8"
        },
        {
            "title": "026627 外盒及標籤-105-03-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026627&Seq=001&Type=8"
        }
    ]
}